ACC: AstraZeneca unveils more SGLT2 heart benefits with latest batch of real-world data
When it comes to real-world heart benefits, SGLT2 diabetes drugs continue to impress.
AstraZeneca revealed here Sunday that in a real-world study of more than 400,00...


















